Arcellx (ACLX) Interest & Investment Income (2024 - 2025)
Arcellx (ACLX) recorded quarterly Interest & Investment Income of $5.6 million in Q4 2025, down 6.61% quarter-over-quarter from $6.0 million in Q3 2025, and down 26.16% on a YoY basis from $7.6 million in Q4 2024.
Arcellx (ACLX) Interest & Investment Income (2024 - 2025) Analysis & Trends
Arcellx's Interest & Investment Income history runs 2 years deep, the most recent figure standing at $5.6 million for Q4 2025.
- In Q4 2025, Interest & Investment Income fell 26.16% year-over-year to $5.6 million; the TTM figure through Dec 2025 stood at $24.2 million (down 27.32% YoY), while the FY2025 annual figure was $24.2 million, down 27.32% from the prior year.
- Interest & Investment Income was $5.6 million for Q4 2025 at Arcellx, down from $6.0 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $9.2 million in Q1 2024 to a low of $5.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.60 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 5.98 Mn |
| Mar 31, 2025 | 6.64 Mn |
| Dec 31, 2024 | 7.58 Mn |
| Sep 30, 2024 | 8.09 Mn |
| Jun 30, 2024 | 8.45 Mn |
| Mar 31, 2024 | 9.20 Mn |